SCHEMBL4533547

SCHEMBL4533547

CS(=O)(=O)Nc1ccccc1-c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.60
MCOLN3 Q8TDD5 3/20 0.60
LMNA P02545 2/20 0.60
CA12 O43570 1/20 0.60
CA2 P00918 1/20 0.60
CA9 Q16790 1/20 0.60
MCL1 Q07820 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.57
L3MBTL1 Q9Y468 2/20 0.55
ALDH1A1 P00352 1/20 0.55
CKS1B P61024 1/20 0.53
GLO1 Q04760 1/20 0.53
SKP2 Q13309 1/20 0.53
CDK1 P06493 1/20 0.52
CDK2 P24941 1/20 0.52
IRAK4 Q9NWZ3 1/20 0.52
KEAP1 Q14145 3/20 0.52
PTGS2 P35354 1/20 0.50
KMT2A Q03164 1/20 0.50
PARP14 Q460N5 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31645593 1.00 KDM1A (0.60) KDM1AMCOLN3LMNACA12CA2
Trifluoromethanesulfonic Acid SCHEMBL29029435 0.87 MCL1 (0.52) KDM1AMCOLN3LMNACA12CA2
SCHEMBL7183442 0.87 LMNA (0.64) KDM1AMCOLN3LMNACA12CA2
SCHEMBL7183438 0.85 KDM1A (0.58) KDM1AMCOLN3LMNACA12CA2
SCHEMBL4699013 0.85 SLC22A12 (0.55) KDM1AMCL1CKS1BGLO1SKP2
SCHEMBL4667179 0.85 MCL1 (0.61) KDM1AMCOLN3LMNACA12CA2
SCHEMBL29788215 0.85 KEAP1 (0.61) KDM1AMCOLN3LMNACA12CA2
SCHEMBL16759968 0.85 KEAP1 (0.61) KDM1AMCOLN3LMNACA12CA2
SCHEMBL3141420 0.85 KDM1A (0.55) KDM1AMCOLN3LMNACA12CA2
SCHEMBL2040317 0.85 MCL1 (0.64) KDM1AMCOLN3LMNACA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 KDM1A 29/4885MCOLN3 4015/4885LMNA 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.